IDEX Accumulated Goodwill Impairment Losses remained flat by 0.0% to $200.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200.60M to $200.60M. Over 5 years (FY 2020 to FY 2025), Accumulated Goodwill Impairment Losses shows relatively stable performance with a -0.0% CAGR.
accumulated_goodwill_impairment| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $200.60M | $200.60M | $200.60M | $200.60M | $200.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% | +0.0% | +0.0% |
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Health & Science Technologies | $149.80M | $149.80M | $149.80M | $149.80M | $149.80M |
| Fire & Safety/Diversified Products | $30.10M | $30.10M | $30.10M | $30.10M | $30.10M |
| Fluid & Metering Technologies | $20.70M | $20.70M | $20.70M | $20.70M | $20.70M |
| Total | $200.60M | $200.60M | $200.60M | $200.60M | $200.60M |
Fire & Safety/Diversified Products, Fluid & Metering Technologies, Health & Science Technologies were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.